167 related articles for article (PubMed ID: 7943168)
1. Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells.
Spuler S; Marx A; Kirchner T; Hohlfeld R; Wekerle H
Am J Pathol; 1994 Oct; 145(4):766-70. PubMed ID: 7943168
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis.
Schönbeck S; Padberg F; Hohlfeld R; Wekerle H
J Clin Invest; 1992 Jul; 90(1):245-50. PubMed ID: 1634612
[TBL] [Abstract][Full Text] [Related]
3. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
Meinl E; Klinkert WE; Wekerle H
Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
[TBL] [Abstract][Full Text] [Related]
4. [Role of the thymus in the physiopathology of myasthenia].
Eymard B; Berrih-Aknin S
Rev Neurol (Paris); 1995 Jan; 151(1):6-15. PubMed ID: 7676132
[TBL] [Abstract][Full Text] [Related]
5. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
Hohlfeld R; Wekerle H
J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study.
Schluep M; Willcox N; Vincent A; Dhoot GK; Newsom-Davis J
Ann Neurol; 1987 Aug; 22(2):212-22. PubMed ID: 3662452
[TBL] [Abstract][Full Text] [Related]
7. [Modulation of experimental myasthenia gravis by IVIg].
Berrih-Aknin S; Aissaoui A; Yamamoto M; Kaveri SV
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S25-9. PubMed ID: 10896985
[TBL] [Abstract][Full Text] [Related]
8. Myf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravis.
Hu B; Simon-Keller K; Küffer S; Ströbel P; Braun T; Marx A; Porubsky S
Exp Neurol; 2016 Mar; 277():76-85. PubMed ID: 26708556
[TBL] [Abstract][Full Text] [Related]
9. Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice.
Spuler S; Sarropoulos A; Marx A; Hohlfeld R; Wekerle H
Am J Pathol; 1996 May; 148(5):1359-65. PubMed ID: 8623907
[TBL] [Abstract][Full Text] [Related]
10. Induction of human gamma delta T cells in myasthenia gravis thymus transplanted SCID mice.
Iwata T; Inoue K; Kato T; Nishida T; Kinoshita H
Osaka City Med J; 1999 Dec; 45(2):109-21. PubMed ID: 10730077
[TBL] [Abstract][Full Text] [Related]
11. Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells.
Wekerle H; Ketelsen UP; Zurn AD; Fulpius BW
Eur J Immunol; 1978 Aug; 8(8):579-82. PubMed ID: 699955
[TBL] [Abstract][Full Text] [Related]
12. [Thymic abnormalities in patients with myasthenia gravis].
Utsugisawa K; Nagane Y
Brain Nerve; 2011 Jul; 63(7):685-94. PubMed ID: 21747138
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
[TBL] [Abstract][Full Text] [Related]
14. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
15. Myoid cells and neuroendocrine markers in myasthenic thymuses.
Zółtowska A; Pawełczyk T; Stopa M; Skokowski J; Stepiński J; Roszkiewicz A; Nyka W
Arch Immunol Ther Exp (Warsz); 1998; 46(4):253-7. PubMed ID: 9779292
[TBL] [Abstract][Full Text] [Related]
16. Rhesus thymic/liver xenografts in severe combined immunodeficient mice: immunologic reconstitution and intrathymic infection with simian immunodeficiency virus.
Binhazim AA; Rizvi TA; Coghlan LG; Lew K; Schmidt R; Wong PK
Lab Invest; 1996 Sep; 75(3):339-48. PubMed ID: 8804357
[TBL] [Abstract][Full Text] [Related]
17. Thymic myoid cells as a myasthenogenic antigen and antigen-presenting cells.
Matsumoto MY; Matsuo H; Oka T; Fukudome T; Hayashi K; Shiraishi H; Motomura M; Shibuya N; Ayabe H
J Neuroimmunol; 2004 May; 150(1-2):80-7. PubMed ID: 15081251
[TBL] [Abstract][Full Text] [Related]
18. An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis.
Salmon AM; Bruand C; Cardona A; Changeux JP; Berrih-Aknin S
J Clin Invest; 1998 Jun; 101(11):2340-50. PubMed ID: 9616205
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
20. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
